Olink

Olink®
Part of Thermo Fisher Scientific

Scientific publications

Discover the latest research using Olink’s panels for protein biomarker discovery through our comprehensive list of publications. Easily find relevant studies by filtering them or using the free-text search.  Access abstracts, PubMed entries, and full-text papers directly through the links provided.

Filter

Filters

Publication
Disease Area
Application Area
Sample Type
Products

Communications Biology, 2025

Systemic cytokines drive conserved severity-associated myeloid responses across bacterial and viral infections

Kajihara K., Yan D., Seim G. et al.

International Urology and Nephrology, 2025

Unraveling the causal link between inflammatory cytokines and hypertensive renal disease: a Mendelian randomization analysis

Gong X., Xu X., He M. et al.

Nature Medicine, 2025

Large language model-based biological age prediction in large-scale populations

Li Y., Huang Q., Jiang J. et al.

Nature Communications, 2025

Genome-wide association study of pulpal and apical diseases

Salminen A., Hyvärinen K., Ritari J. et al.

Translational Psychiatry, 2025

Exosomes from high-altitude cerebral edema patients induce cognitive dysfunction by altering oxidative stress responses in mice

Fu Q., Qiu R., Tang Q. et al.

Alzheimer's Research & Therapy, 2025

CHIT1 and DDAH1 levels relate to amyloid-related imaging abnormalities risk profile in Alzheimer’s disease patients

Oosthoek M., Vijverberg E., Blujdea E. et al.

Cell, 2025

Functional liver genomics identifies hepatokines promoting wasting in cancer cachexia

Kaltenecker D., Fisker Schmidt S., Weber P. et al.

Signal Transduction and Targeted Therapy, 2025

Exploratory phase II trial of an anti-PD-1 antibody camrelizumab combined with a VEGFR-2 inhibitor apatinib and chemotherapy as a neoadjuvant therapy for triple-negative breast cancer (NeoPanDa03): efficacy, safety and biomarker analysis

Liu X., Zhuang C., Liu L. et al.

International Journal of Molecular Sciences, 2025

Hydroxytyrosol Reprograms the Tumor Microenvironment in 3D Melanoma Models by Suppressing ERBB Family and Kinase Pathways

Tovar-Parra D., Mangion M.

Journal of Pineal Research, 2025

Proteomic Signatures Underlying Sleep, Circadian Activity Patterns, and Major Chronic Diseases

Wei J., Wu H., Zheng Y. et al.

Journal of Cardiology, 2025

Proteome-wide Mendelian randomization and colocalization analyses identify novel protein targets for cardiac conduction disorders

Song Z., Xu Y., Chen Y. et al.

Multiple Sclerosis and Related Disorders, 2025

Proximity Extension Assay identifies new targets of grey matter pathology in multiple sclerosis

van der Stok H., Coenen L., Weil M. et al.

npj Precision Oncology, 2025

Circulating T-cell receptor repertoire for cancer early detection

Li Y., Nahas M., Stephens D. et al.

eBioMedicine, 2025

The influence of metformin treatment on the circulating proteome

Connolly B., McCreight L., Slieker R. et al.

Science Immunology, 2025

Interactions between placental Hofbauer cells and L. monocytogenes change throughout gestation

Yoshida N., Appios A., Li Q. et al.

Science Immunology, 2025

Tissue origin and virus specificity shape human CD8 + T cell cytotoxicity

Niessl J., Müller T., Constantz C. et al.

Cancer Letters, 2025

PAF signaling axis functions as biomarker or target for esophageal squamous cell carcinoma diagnosis or treatment

Zhu Y., Wang F., Zhu Y. et al.

Translational Stroke Research, 2025

FLT1 as a Protective Factor in Ischemic Stroke: Insights from Real-World Pharmacovigilance and Genetic Evidence

Chen H., Yang J., Li Z. et al.

Atherosclerosis, 2025

Different plasma biomarker patterns associated with coronary atherosclerosis in low- versus high-risk individuals – an observational cross-sectional study

Cederström S., Wang Y., Lundman P. et al.

British Journal of Dermatology, 2025

Mendelian randomization identifies OX40 as a potential mediator of the effects of cigarette smoking in palmoplantar pustulosis

Smail A., Dand N., Liu X. et al.

4586 publications